It also activates oxidative stress-responsive transcription factors (e.g., AP-1, NF-κB), upregulating IL-8 and MMPs to facilitate epithelial-mesenchymal transition and tumor invasion [46]. The gene discussed is CXCL8; the disease is neoplasm.